Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
1.640
-0.120 (-6.82%)
At close: Sep 30, 2026, 4:00 PM EDT
1.720
+0.080 (4.88%)
After-hours: Sep 30, 2026, 7:40 PM EDT

Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $5.50 million. The enterprise value is $5.30 million.

Market Cap5.50M
Enterprise Value 5.30M

Important Dates

The next estimated earnings date is Thursday, November 5, 2026, after market close.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

PCSA has 3.35 million shares outstanding. The number of shares has increased by 652.98% in one year.

Current Share Class 3.35M
Shares Outstanding 3.35M
Shares Change (YoY) +652.98%
Shares Change (QoQ) +4.86%
Owned by Insiders (%) 3.10%
Owned by Institutions (%) 24.70%
Float 3.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.87

Current Ratio 0.87
Quick Ratio 0.08
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -464.20% and return on invested capital (ROIC) is -276.38%.

Return on Equity (ROE) -464.20%
Return on Assets (ROA) -156.79%
Return on Invested Capital (ROIC) -276.38%
Return on Capital Employed (ROCE) 4,051.82%
Weighted Average Cost of Capital (WACC) 9.57%
Revenue Per Employee n/a
Profits Per Employee -$1.12M
Employee Count12
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -65.53% in the last 52 weeks. The beta is 0.97, so PCSA's price volatility has been similar to the market average.

Beta (5Y) 0.97
52-Week Price Change -65.53%
50-Day Moving Average 2.15
200-Day Moving Average 2.58
Relative Strength Index (RSI) 34.34
Average Volume (20 Days) 26,643

Short Selling Information

The latest short interest is 14,995, so 0.45% of the outstanding shares have been sold short.

Short Interest 14,995
Short Previous Month 35,949
Short % of Shares Out 0.45%
Short % of Float 0.46%
Short Ratio (days to cover) 0.46

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -12.86M
Pretax Income -13.44M
Net Income -13.44M
EBITDA -12.86M
EBIT -12.86M
Earnings Per Share (EPS) -$5.59
Full Income Statement

Balance Sheet

The company has $196,325 in cash and no debt, with a net cash position of $196,325 or $0.06 per share.

Cash & Cash Equivalents 196,325
Total Debt n/a
Net Cash 196,325
Net Cash Per Share $0.06
Equity (Book Value) -317,341
Book Value Per Share -0.11
Working Capital -320,551
Full Balance Sheet

Cash Flow

Operating Cash Flow -11.97M
Capital Expenditures n/a
Depreciation & Amortization 1,204
Net Borrowing -3,752
Free Cash Flow -11.97M
FCF Per Share -$3.57
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -652.98%
Shareholder Yield -652.98%
Earnings Yield -250.58%
FCF Yield -223.23%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on December 17, 2025. It was a reverse split with a ratio of 1:25.

Last Split Date Dec 17, 2025
Split Type Reverse
Split Ratio 1:25

Scores

Altman Z-Score n/a
Piotroski F-Score 1